Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dopamine release at presynaptic site" refers not to an individual molecule or receptor but **to the physiological process by which dopaminergic neurons secrete the neurotransmitter dopamine into the synapse from their axon terminals. This occurs primarily through exocytosis triggered by action potentials and involves vesicular monoamine transporter VMAT2 loading vesicles with dopamine prior to fusion with the presynaptic membrane. The released dopamine then acts on postsynaptic receptors as well as presynaptic autoreceptors that regulate further synthesis and release. This tightly regulated mechanism is central for normal brain function—including movement control, reward processing, motivation, learning—and its dysregulation underlies several neuropsychiatric diseases such as Parkinson's disease and addiction.[1][3][6]** Drugs such as amphetamines can induce non-exocytic ("reverse transport") release independent from normal neuronal firing patterns,[4] while others like cocaine block reuptake transporters leading to increased extracellular concentrations.[1][4] The regulation of this process involves multiple feedback loops including D2-type autoreceptors on dopaminergic neurons themselves.[3] Recent research also highlights roles for nicotinic acetylcholine receptors on axons in modulating local action potential initiation and subsequent transmitter secretion near terminal fields.[5]
Promotion of non-exocytic dopamine efflux via reverse transporters (amphetamines)[4]; Inhibition of dopamine reuptake transporter to increase synaptic levels (cocaine)[4]; Modulation of vesicular monoamine transporter activity and exocytosis mechanisms[1][4]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine release at presynaptic site.